Wenxin Keli for Ventricular premature complexes with Heart failure: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
CONCLUSIONS: Wenxin Keli may be effective and safe for treating VPCs and HF. However, further RCTs of larger scale, multi-center/country, longer follow-up periods, and higher quality are still required to verify the efficacy of Wenxin Keli in ventricular premature beat with heart failure.
PMID: 28735831 [PubMed - in process]
Source: Complementary Therapies in Medicine - Category: Complementary Medicine Authors: Li M, Qiu R, Tian G, Zhang X, Li C, Chen S, Zhang Q, Shang H Tags: Complement Ther Med Source Type: research
More News: Alternative and Complementary Therapies | Cardiology | Clinical Trials | Databases & Libraries | Heart | Heart Failure | Statistics | Study